THE ADVERSE DRUG REACTIONS REPORTED IN THE DEPARTMENT OF PSYCHIATRY IN A TERTIARY CARE HOSPITAL IN CHENNAI

Main Article Content

P. NITHYA
. SANTHANALAKSHMI

Abstract

Aim: The Adverse Drug Reaction related to the psychotropic drugs is important aspect for the completion of the treatment regime and solely based on the awareness of the drug.

Method: The present study aimed to analyse the awareness and the impacts on the patients related to the usage of aripiprazole as the psychotic drug in inpatient ward at Chennai based hospital. The CDSCO Adverse Drug Reaction reporting form with specified the ADRs was used to analyzing the events in patients.

Results: The metabolic changes associated with aripiprazole were insignificant but, olanzapine showed severe changes in respective patients was the main focus of the present study.

Conclusion: The clinical uses of the aripiprazole were higher than its side effects and the present study showed its severity of the side effects. Meanwhile, this required enough time for ensuring the future promises.

Keywords:
Adverse drug reaction, causative drugs, drug interactions, preventable reactions, serious reactions

Article Details

How to Cite
NITHYA, P., & SANTHANALAKSHMI, . (2021). THE ADVERSE DRUG REACTIONS REPORTED IN THE DEPARTMENT OF PSYCHIATRY IN A TERTIARY CARE HOSPITAL IN CHENNAI. UTTAR PRADESH JOURNAL OF ZOOLOGY, 42(24), 280-282. Retrieved from http://mbimph.com/index.php/UPJOZ/article/view/2692
Section
Original Research Article

References

Hall RCW, Popkin M, Kirkpatrick B: Tricyclic exacerbation of steroid psychosis. JNerv Ment Dis. 1978;166(10):738-742.

Hall RCW(ed): Psychiatric Presentations of Medical Illness: Somatopsychic Disorders.New York, Spectrum Publications; 1980.

Haupt DW, Newcomer JW. Hyperglycemia an antipsychotic medications. J Clin Psychiatry. 2001;62(suppl 27):15-26.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.

Hedenmalm K, Hagg S, Stahl M, Mortimer, Spigset O. Glucose intolerance with atypical antipsychotics. Drug Safety - Adis International. 2002;25(15):1107-1016.

Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. Journal of Psychopharmacology. 2005;19 (suppl.):16-27.

Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs. 2002;62:1649Al 671.

Haddad PM, Dursun S. Selecting antipsychotics in schizophrenia: lessons from CATIE. Journal of Psychopharmacology. 2006;20:332-334.

Haro JM, Suarez D, Novick D, et al. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results. European Neuropsychopharmacology. 2007;17:235-244.

Hasler G, Moergeli H, Bachmann R, et al. Patient satisfaction with outpatient psychiatric treatment: the role of diagnosis, pharmacotherapy, and perceived therapeutic change. Canadian Journal of Psychiatry. 2004;49:315-321.